0001694665-21-000029.txt : 20210201 0001694665-21-000029.hdr.sgml : 20210201 20210201170714 ACCESSION NUMBER: 0001694665-21-000029 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210127 FILED AS OF DATE: 20210201 DATE AS OF CHANGE: 20210201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zung Jonathan B. CENTRAL INDEX KEY: 0001837972 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38473 FILM NUMBER: 21577649 MAIL ADDRESS: STREET 1: C/O EVELO BIOSCIENCES, INC. STREET 2: 620 MEMORIAL DRIVE, SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evelo Biosciences, Inc. CENTRAL INDEX KEY: 0001694665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465594527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 620 MEMORIAL DRIVE STREET 2: SUITE 200 WEST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617 870 8281 MAIL ADDRESS: STREET 1: 620 MEMORIAL DRIVE STREET 2: SUITE 200 WEST CITY: CAMBRIDGE STATE: MA ZIP: 02139 4/A 1 wf-form4a_161221722128198.xml FORM 4/A X0306 4/A 2021-01-27 2021-01-29 0 0001694665 Evelo Biosciences, Inc. EVLO 0001837972 Zung Jonathan B. C/O EVELO BIOSCIENCES, INC. 620 MEMORIAL DRIVE CAMBRIDGE MA 02139 0 1 0 0 Chief Development Officer Stock Option (Right to Buy) 16.65 2021-01-27 4 A 0 300000 0 A 2031-01-27 Common Stock 300000.0 300000 D Restricted Stock Units 0.0 2021-01-27 4 A 0 10000 0 A Common Stock 10000.0 10000 D This option will vest as to 25% of the total grant on January 4, 2022 and as to the remaining 75% vesting thereafter in thirty-six (36) substantially equal monthly installments, subject to continued employment on such dates. These Restricted Stock Units will vest in full on the third anniversary of the grant date, January 27, 2024, subject to continued employment on such date. This Form 4/A is being filed to correct an administrative error and include all awards granted to the reporting person on January 27, 2021. /s/ Daniel S. Char, Attorney-in-Fact for Jonathan B. Zung 2021-02-01